Description:
NEURAMINIDASE DEFICIENCY
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Lysosomal Storage Diseases |
Class |
Disorders of Carbohydrate Metabolism |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
White
|
Family Member
|
3
|
Relation to Proband
|
mother
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
9 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase Isoenzyme Electrophoresis |
|
exo-alpha-sialidase |
According to the submitter, biochemical test results for this subject showed decreased enzyme activity. EC Number: 3.2.1.18; 62% activity. |
|
Remarks |
62% of normal sialidase activity using NAN-lactose as substrate; clinically unaffected mother of GM02921 |
dbSNP |
dbSNP ID: 15144 |
Gene Cards |
NEU |
NCBI GTR |
256550 NEURAMINIDASE DEFICIENCY |
OMIM |
256550 NEURAMINIDASE DEFICIENCY |
Omim Description |
CHERRY RED SPOT AND MYOCLONUS SYNDROME |
|
GLYCOPROTEIN NEURAMINIDASE, DEFICIENCY OF |
|
LIPOMUCOPOLYSACCHARIDOSIS, INCLUDED |
|
ML I, INCLUDED |
|
MUCOLIPIDOSIS I, INCLUDED |
|
MYOCLONUS AND CHERRY RED SPOT SYNDROME |
|
NEU, DEFICIENCY OF |
|
NEU1, DEFICIENCY OFNEURAMINIDASE, INCLUDED; NEU, INCLUDED |
|
NEUG, DEFICIENCY OF |
|
NEURAMINIDASE 1, DEFICIENCY OF |
|
NEURAMINIDASE DEFICIENCY |
|
SIALIDASE DEFICIENCY |
|
SIALIDOSES, TYPES I AND II |
Passage Frozen |
9 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|